$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
12 Potent Picks Are December's Ideal Dividend Buys
10:04am, Tuesday, 29'th Nov 2022
A February 2, 2022, Kiplinger Today special report headlined, "Potent Picks to Profit in 2022,” featured 97 dividend-fetching stocks from 118 in that article. Here is YCharts 11/25/22 update. Articl
Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%
01:31pm, Friday, 25'th Nov 2022 Benzinga
Barclays cut Medtronic plc (NYSE: MDT) price target from $90 to $85. Medtronic shares gained 0.5% to $79.40 in pre-market trading.
Oppenheimer slashed Gain Therapeutics, Inc. (NASDAQ: GANX) price
Universal Health Services To Rally Around 25%? Here Are 5 Other Price Target Changes For Friday
12:51pm, Friday, 25'th Nov 2022 Benzinga
Credit Suisse raised Universal Health Services, Inc. (NYSE: UHS) price target from $129 to $157. Credit Suisse analyst Jonathan Yong maintained an Outperform rating on the stock. Universal Health fe
Should You Buy Medtronic Stock At $80?
08:00am, Friday, 25'th Nov 2022
The recent fall can be attributed to the Q2FY23 results the company reported yesterday, with revenue falling below and earnings above our estimates.
My Best Dividend Aristocrats For December 2022
02:33pm, Thursday, 24'th Nov 2022 Seeking Alpha
I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. Click here to read about my portfolio performance thus far and future plans.
My Best Dividend Aristocrats For December 2022
09:33am, Thursday, 24'th Nov 2022
NOBL gained 10.31% in October, which brings the Fund's return for the year to a loss of 8.96%. Thus far this month, through November 22nd, the dividend aristocrat ETF is up 6.52%, bringing its year-to
What 10 Analyst Ratings Have To Say About Medtronic
06:02pm, Wednesday, 23'rd Nov 2022 Benzinga
Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
7
0
0
Last 30D
0
1
10 Analysts Have This to Say About Medtronic
05:04pm, Wednesday, 23'rd Nov 2022 Benzinga
Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
7
0
0
Last 30D
0
1
3
Tesla To $176? Here Are 5 Other Price Target Changes For Wednesday
12:14pm, Wednesday, 23'rd Nov 2022 Benzinga
Citigroup raised Tesla, Inc. (NASDAQ: TSLA) price target from $141.33 to $176. . Citigroup analyst Itay Michaeli upgraded the stock from Sell to Neutral. Tesla shares rose 1.2% to close at $169.91 o
Analyst Ratings for Medtronic
12:02pm, Wednesday, 23'rd Nov 2022 Benzinga
Analysts have provided the following ratings for Medtronic (NYSE:MDT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
5
0
0
Last 30D
These 2 Stocks Just Made Surprising Moves
11:45pm, Tuesday, 22'nd Nov 2022 The Motley Fool
Markets had a strong day.
Medtronic (MDT) Q2 2023 Earnings Call Transcript
08:30pm, Tuesday, 22'nd Nov 2022 The Motley Fool
MDT earnings call for the period ending September 30, 2022.
Medtronic Stock Falls After Medical-Device Maker Posts Lower Earnings
06:51pm, Tuesday, 22'nd Nov 2022
Supply-chain and demand challenges pressure the Dublin-based company's latest quarterly results.
These 2 Stocks Just Made Surprising Moves
06:45pm, Tuesday, 22'nd Nov 2022
Markets had a strong day.
Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down
05:47pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Medtronic's (MDT) Q2 organic revenues reflect slower supply recovery and lower-than-anticipated underlying market procedure volumes in certain businesses.
Sign In
Buy MDT